Scholar Rock Quarterly Balance Sheet
NASDAQ: SRRKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Scholar Rock financial position
As of Jun 30, 2026, Scholar Rock reported total assets of $523.5 million, up 54.0% from a year earlier against total liabilities of $269.8 million. Shareholders' equity stood at $253.8 million, or 48.5% of assets. The company held $437.1 million in cash and equivalents against $196.2 million of debt, a net cash position of $240.9 million.
The current ratio (current assets divided by current liabilities) was 7.02, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.77.
Summary generated from market data by MetaCap's automated system. Methodology
Scholar Rock balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 437.09M | 430.54M | 323.53M | 286.77M | 152.93M | 137.93M | 177.88M | 76.39M | 93.37M | 91.98M | 101.86M | 67.60M |
| Short-Term Investments | 55.00M | 49.40M | 44.04M | 82.86M | 142.09M | 226.45M | 259.40M | 62.67M | 97.12M | 146.45M | 178.08M | 151.04M |
| Total Current Assets | 507.18M | 515.28M | 385.15M | 390.71M | 319.13M | 385.25M | 451.17M | 152.93M | 199.14M | 246.93M | 288.19M | 228.47M |
| Property, Plant & Equipment | 1.17M | 1.44M | 1.71M | 2.12M | 2.44M | 2.64M | 2.76M | 3.16M | 3.55M | 4.04M | 4.60M | 5.28M |
| Total Assets | 523.54M | 535.25M | 404.27M | 411.72M | 340.05M | 407.55M | 474.92M | 179.13M | 226.87M | 267.29M | 311.04M | 250.69M |
| Accounts Payable | 10.99M | 9.22M | 10.30M | 6.76M | 1.10M | 4.44M | 10.10M | 4.07M | 3.31M | 2.87M | 3.46M | 1.97M |
| Short-Term Debt | — | — | — | — | — | — | — | — | 1.59M | 5.50M | 1.33M | — |
| Total Current Liabilities | 72.24M | 59.64M | 55.42M | 61.97M | 50.44M | 37.57M | 46.94M | 39.37M | 32.99M | 37.51M | 32.74M | 26.73M |
| Long-Term Debt | 196.20M | 196.61M | 99.71M | 99.61M | 49.76M | 49.74M | 50.15M | 50.10M | 48.48M | 44.59M | 48.68M | 49.96M |
| Total Liabilities | 269.76M | 259.24M | 158.78M | 166.72M | 106.75M | 95.22M | 106.29M | 99.94M | 93.25M | 84.51M | 85.82M | 83.02M |
| Shareholders' Equity | 253.78M | 276.01M | 245.49M | 245.00M | 233.29M | 312.33M | 368.63M | 79.20M | 133.62M | 182.77M | 225.22M | 167.66M |
| Retained Earnings | -1.52B | -1.41B | -1.30B | -1.21B | -1.11B | -997.44M | -922.72M | -856.26M | -791.78M | -733.27M | -676.42M | -630.29M |
| Total Debt | 196.20M | 196.61M | 99.71M | 99.61M | 49.76M | 49.74M | 50.15M | 50.10M | 50.07M | 50.09M | 50.02M | 49.96M |
| Net Cash (Debt) | 295.88M | 283.33M | 267.85M | 270.02M | 245.26M | 314.63M | 387.13M | 88.97M | 140.42M | 188.34M | 229.92M | 168.68M |
| Shares Outstanding | 121.60M | 119.10M | 108.46M | 99.17M | 96.00M | 94.87M | 93.82M | 80.08M | 79.99M | 79.74M | 75.98M | 56.26M |
This table shows 12 quarterly periods of Scholar Rock's balance sheet, from Q2 2026 back to Q3 2023, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SRRK's reporting calendar. What is a balance sheet?